By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 2nd iPSC-Derived Cell Therapies Summit Showcasing Discovery, Translation, CMC and Regulatory Advances at the Flagship iPSC Summit Continued investment into the iPSC space is accelerating development of both autologous and off-the-shelf therapies for a broad range of indications.
Connect with the community driven to create best-in-class, safe & effective iPSC-derived therapies.
Explore approaches to boost safe gene-editing, approach regulatory affairs; develop cell engineering protocol to produce efficacious products & more.
Discover more about turbocharge scale-up, optimize analytics and more to produce best-in-class therapies for immuno-oncology and regenerative medicine.
Hear from experts of top companies like Century Therapeutics, Novo Nordisk & ReNeuron, to solve your differentiation, quality & engineering challenges.
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Event Started
USA
Paid
Boston
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
STEMCELL Technologies is a biotechnology company that develops specialty cell culture media and cell separation products to support research in the fields of immunology, hematology, neuroscience, mesenchymal cell, stem cell and epithelial cell biolog
At Lonza, we enable #AHealthierWorld by supporting our healthcare customers on the path to commercialization.
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.